MicroRNA (miRNA) Market Key Players, Opportunities, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: MicroRNA (miRNA) Market covers analysis By Product (Instruments, Consumables); Services (Sample Collection, miRNA cDNA Synthesis, miRNA Profiling and Purification, Next Generation Sequencing (NGS), Microarray, Real Time PCR (RT-PCR), Others); Application (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Disorders, Infectious Diseases, Others); End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00006698
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The MicroRNA (miRNA) Market is expected to register a CAGR of 13% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The MicroRNA (miRNA) Market report covers segmental analysis by Product (Instruments, Consumables), Services (Sample Collection, miRNA cDNA Synthesis, miRNA Profiling and Purification, Next Generation Sequencing (NGS), Microarray, Real Time PCR (RT-PCR), Others), Application (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Disorders, Infectious Diseases, Others), End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries

Purpose of the Report

The report MicroRNA (miRNA) Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

MicroRNA (miRNA) Market Segmentation

Product

  • Instruments
  • Consumables

Services

  • Sample Collection
  • miRNA cDNA Synthesis
  • miRNA Profiling and Purification
  • Next Generation Sequencing
  • Microarray
  • Real Time PCR

Application

  • Cardiovascular Diseases
  • Cancer
  • Neurological Diseases
  • Immunological Disorders
  • Infectious Diseases

End User

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

MicroRNA (miRNA) Market: Strategic Insights

microrna-mirna-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MicroRNA (miRNA) Market Growth Drivers

  • Expanding Applications in Regenerative Medicine: Regenerative medicine encompasses the repairing or replacement of tissues and organs after damage. Here is a substantial impact area in which miRNAs intervene, enhancing the stem cell differentiation of tissues that eventually regenerate and heal the wounds. With a potential role to modulate cellular behavior, these miRNAs are among the best candidates to be developed in applications concerning regenerative medicine. As there has been increasing interest in demand for regenerative therapies, the miRNA market also tends to get investments in developing solutions concerning the miRNAs.
  • Growing Awareness of miRNA's Potential in Agriculture: The microRNA market is not limited to the health sector alone but extends its benevolent hand towards agriculture too. miRNAs help in plant growth, stress resistance, and crop development. miRNA-based technologies are used for increasing crop yield, resistance to pests, and nutritional content, thereby contributing to agricultural produce. With advancing agricultural biotechnology, miRNA applications are of great importance and contribute to the overall growth of the market.
  • Favorable Regulatory Environment: Also, miRNAs are helping support the diagnostics and therapeutics segment, leading to a relatively easier regulatory landscape to develop and bring to the market. In particular, increasing numbers of regulatory authorities such as the FDA in the United States and the EMA in Europe, appear increasingly favorable toward products utilizing miRNA, further streamlining market access. More favorably placed regulation also spurs investment into the research in the miRNAs area, accelerating market growth for companies involved in such activity.

MicroRNA (miRNA) Market Future Trends

  • Development of miRNA-Based Vaccines: Another emerging trend in the MicroRNA (miRNA) market, is implemented into the market. miRNAs can regulate and change the immune responses of the organisms to increase effectiveness and strength; they therefore provide organisms with increased defense mechanisms against infections and diseases. With the increased vaccination demands around the world, especially post the COVID-19 pandemic, miRNA-based vaccine technologies offer the possibility of speedier, more targeted options and a new growth road for the miRNA market.
  • Rise of miRNA Biomarkers in Liquid Biopsy: Liquid biopsy is an increasingly popular non-invasive diagnostic technique in the medical field, and miRNAs are playing a crucial role in this trend. miRNAs are mostly found in body fluids, such as blood, urine, and saliva and are great candidates for liquid biopsy; thus, the disease can be diagnosed and monitored at earlier stages for cancer diseases and cardiovascular diseases, and therefore, the growth in acceptance of technologies based on liquid biopsy will augment demand for miRNA-based biomarkers and this will increase the market for MicroRNA (miRNA).
  • Personalized Medicine and Targeted Therapies: The future growth of the MicroRNA (miRNA) market has a strong nexus with the increased growth of targeted therapies and personalized medicines. Increasingly, in modern medicine, the function of miRNAs is becoming gradually recognized as it dictates the course and type of medication to be provided to a given patient based on their genetic makeup; therefore, personalization. Based on advancements achieved in genomic sequencing and bioinformatics, miRNA-based solutions may become the corner stone in the arena of personalized medicine-precise effective, and low-invasive.

MicroRNA (miRNA) Market Opportunities

  • Emergence of miRNA in Agriculture and Plant Biotechnology: The agriculture sector has already adopted miRNAs and will expand in the coming years. In agriculture, miRNAs have been utilized to enhance crop yield, pest resistance, and tolerance to stress in plants. Due to food security being a massive issue worldwide, the demand for genetically modified crops and advanced agricultural solutions will raise the adoption of miRNA technologies. Agricultural application is one of the biggest opportunities for microRNA.
  • Advances in miRNA Delivery Systems: Although the delivery aspect did pose some earlier concerns, this has now turned out to be one of the major bottlenecks of the miRNA field. There is some significant progress made concerning the delivery systems comprising lipid nanoparticles, viral vectors, and exosomes that would promise higher efficiency along with specificity in the targeting of the miRNA-based therapeutics. These innovations will make the miRNA-based treatments both more effective and less likely to cause side effects, making them clinically and commercially more viable. Hence, the need for these delivery systems will lead to an expansion of the microRNA (miRNA) market.
  • Increased Collaboration Between Academia and Industry: Since the scope of applications for miRNAs is expanding, it will lead to the increasing collaboration of academic research institutions with industry players. These collaborations will bring novel miRNA-based therapies, diagnostics, and technologies to the fore. Partnerships between biotechnology companies, pharmaceutical firms, and academic institutions are expected to quicken the innovative pace of the miRNA market, thus inviting better products and solutions to come onto the market. Trendlines are likely to strengthen the growth track of the miRNA market further.

MicroRNA (miRNA) Market Regional Insights

The regional trends and factors influencing the MicroRNA (miRNA) Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses MicroRNA (miRNA) Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

microrna-mirna-market-global-geography
  • Get the Regional Specific Data for MicroRNA (miRNA) Market

MicroRNA (miRNA) Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 13%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Instruments
  • Consumables
By Services
  • Sample Collection
  • miRNA cDNA Synthesis
  • miRNA Profiling and Purification
  • Next Generation Sequencing
  • Microarray
  • Real Time PCR
By Application
  • Cardiovascular Diseases
  • Cancer
  • Neurological Diseases
  • Immunological Disorders
  • Infectious Diseases
By End User
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Horizon Discovery Ltd.
  • Synlogic
  • QIAGEN
  • GeneCopoeia, Inc.
  • New England Biolabs
  • Quantabio
  • NanoString

  • MicroRNA (miRNA) Market Players Density: Understanding Its Impact on Business Dynamics

    The MicroRNA (miRNA) Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the MicroRNA (miRNA) Market are:

    1. Merck KGaA
    2. Thermo Fisher Scientific, Inc.
    3. Horizon Discovery Ltd.
    4. Synlogic
    5. QIAGEN
    6. GeneCopoeia, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    microrna-mirna-market-cagr

    • Get the MicroRNA (miRNA) Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the MicroRNA (miRNA) Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the MicroRNA (miRNA) Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What is the expected CAGR of the MicroRNA (miRNA) Market?

    The MicroRNA (miRNA) Market is expected to register a CAGR of 13% from 2025-2031.

    What are the driving factors impacting the MicroRNA (miRNA) Market?

    The major factors impacting the MicroRNA (miRNA) Market are: Expanding Applications in Regenerative Medicine, Growing Awareness of miRNA's Potential in Agriculture and Favorable Regulatory Environment

    What are the future trends in the MicroRNA (miRNA) Market?

    Key future trends in this market are - Development of miRNA-Based Vaccines, Rise of miRNA Biomarkers in Liquid Biopsy and Personalized Medicine and Targeted Therapies

    Which are the key players in the MicroRNA (miRNA) Market?

    Key companies of this market are: Merck KGaA, Thermo Fisher Scientific, Inc., Horizon Discovery Ltd., Synlogic, QIAGEN, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString

    What are the deliverable formats of MicroRNA (miRNA) Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Merck KGaA
    2. Thermo Fisher Scientific, Inc.
    3. Horizon Discovery Ltd.
    4. Synlogic
    5. QIAGEN
    6. GeneCopoeia, Inc.
    7. New England Biolabs
    8. Quantabio
    9. NanoString
    10. BioGenex
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo